YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Therapeutic Duplication Criteria Development of Respiratory System Drugs

호흡기계 작용 약물의 치료군 중복처방 평가기준 개발

  • Received : 2012.01.17
  • Accepted : 2012.04.05
  • Published : 2012.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: To develop therapeutic duplication criteria for the drugs used for respiratory diseases. Method: Therapeutic duplication was defined as "more than 2 drug ingredient-usage in which each has the same therapeutic effect and combination therapy does not confer additional therapeutic benefit". Respiratory system drugs approved in Korea were examined for the study. The WHO's Anatomical Therapeutic Chemical Classification System was used for grouping of the corresponding drug ingredients. The principles and recommendations on combination usage or multiple drug regimens were reviewed by using the clinical practice guidelines, textbooks, product labelings, and clinical articles. Clinical expert group consultation was performed and expert opinions were incorporated into the final criteria. Results: Nine hundred sixty two drug products with Korean Food and Drug Administration classification codes of 141, 149, 222, and 229 were evaluated, of which 87 active ingredients were composed. The drug ingredients were classified into 12 groups (antihistamines, oral nasal decongestants, leukotriene receptor antagonists, inhaled anticholinergics, inhaled corticosteroids, oral ${\beta}2$-agonists, long-acting ${\beta}2$-agonists, short-acting ${\beta}2$-agonists, xanthines, antiallergics, mucolytics and cough suppressants). The use of more than 2 drug ingredients including the same group was therapeutic duplication, and thus combination should be recommended not to be used. Conclusion: Twelve drug groups were identified as therapeutic duplication criteria. Combination therapy within each group should not be used otherwise therapeutic benefits outweigh potential risks.

Keywords

References

  1. 건강보험심사평가원 : 약제정보 - 처방.조제안전정보(DUR). Avaialbe at http://www.hira.or.kr/rfl_dur_freeboard_public.do? method=listFreeBoard&bbrd_no=36&pgmid=HIRAB0304020 00000. Accessed on August 2 (2010).
  2. Omnibus Budget Reconciliation Act 1990 (OBRA'90) : Available at http://faculty.ksu.edu.sa/hisham/Documents/Pharmacy_Docs/omnibus.pdf. Accessed on August 2 (2010).
  3. (주)퍼스트디스 : 의료급여 환자별 의약품 적정사용 실태조사 연구보고서 (2006. 4. 21).
  4. 전혜숙 : 노인 외래환자의 의약품 사용평가. 성균관대학교 임상약학대학원 석사학위 논문 (2009).
  5. 신현택 : 중복치료 의약품에 대한 적정사용정보 개발. 식품의약품안전청 연구보고서 (2009. 11).
  6. 식품의약품안전청 : 의약품 등 정보. Available at http://ezdrug.kfda.go.kr/kfda2. Accessed on August 4 (2010).
  7. 대한약사회 : 의약품사용평가(DUR) 학술정보자료집 (2004).
  8. Meredith, S., Feldman, P. H., Frey, D., Hall, K., Arnold, K., Brown, N. J. and Ray, W. A. : Possible medication errors in home healthcare patients. J. Am. Geriatr. Soc. 49, 719 (2001).
  9. Azoulay, L., Zargarzadeh, A., Salahshouri, Z., Oraichi, D. and Berard, A. : Inappropriate medication prescribing in community-dwelling elderly people living in Iran. Eur. J. Clin. Pharmacol. 61, 913 (2005).
  10. 식품의약품안전청 : 의약품등 분류번호에 관한 규정. 식품의약품안전청 예규 제 196호 (2009. 8. 24).
  11. WHO Collaborating Centre for Drug Statistics Methodology : About the ATC/DDD system. Available at http://www.whocc.no/atcddd/. Accessed on August 3 (2010).
  12. Joseph T. Dipiro, Robert L. Talbert, Gary C. Yee, Gary R. matzke, Barbara G. Wells, L. and Michael Posey. : Pharmacotherapy A Pathophysiologic Approach 7th ed. Mc Graw Hill. pp. 1565-1575 (2008).
  13. Joint Task Force on Practice Parameters : Attaining optimal asthma control: a practice parameter. J. Allergy Clin. Immunol. 116, S3-11 (2005).
  14. Bousquet, J., Reid, J., van Weel, C., Baena Cagnani, C., Canonica, G. W., Demoly, P., Denburg, J., Fokkens, W. J., Grouse, L., Mullol, K., Ohta, K., Schermer, T., Valovirta, E., Zhong, N. and Zuberbier, T. : Allergic rhinitis management pocket reference 2008. Allergy 63, 990 (2008).
  15. Potter, P. C., Carte, G., Davis, G., Desmarais, P., Friedman, R., Gill, M., Gravet, C., Green, R., Groenewald, M., Hockman, M., Jeena, P., Jooma, O., Joyce, G., Manjra, A., Ossip, M., Seedat, R., Vidjak, D. and Wolff, L. : Allergy Society of South Africa Consensus. : Clinical management of allergic rhinitis - the Allergy Society of South Africa Consensus Update. South African Medical Journal 96, 1269 (2006).
  16. Price, D., Bond, C., Bouchard, J., Costa, R., Keenan, J., Levy, M. L., Orru, M., Ryan, D., Walker, S. and Watson, M. : International Primary Care Respiratory Group (IPCRG) Guidelines: Management of allergic rhinitis. Primary Care Respiratory Journal 15, 58 (2006).
  17. Institute for Clinical Systems Improvement (ICSI), Clinical Management of Allergic Rhinitis-the Allergy Society of South Africa Consensus Update, (2006). Available at http:// www.icsi.org/respiratory_illness_in_children_and_adults_guideline_/respiratory_illness_in_children_and_adults_ guideline_13116.html. Accessed on September 2 (2009).
  18. Allergic Rhinitis and its Impact on Asthma Workshop Group : Allergic rhinitis and its impact on asthma (ARIA). Allergy 63, 8 (2008).
  19. van Cauwenberge, P., Bachert, C., Passalacqua, G., Bousquet, J., Canonica, G. W., Durham, S. R., Fokkens, W. J., Howarth, P. H., Lund, V., Malling, H. J., Mygind, N., Passali, D., Scadding, G. K. and Wang, D. Y. : Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 55, 116 (2000).
  20. 대한비과학회, 알레르기비염 치료의 가이드라인 요약본 2003. Available at http://www.guideline.or.kr/. Accessed on September 5 (2009).
  21. 이종명 : 알레르기비염의 진단과 치료. 대한내과학회지 76, 268 (2009).
  22. Pratter, M. R. : Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines. Chest. 129, 63S (2006).
  23. Pratter, M. R.: Cough and the common cold: ACCP evidencebased clinical practice guidelines. Chest. 129, 72S (2006).
  24. Brown, K. K. : Chronic cough due to nonbronchiectatic suppurative airway disease (bronchiolitis): ACCP evidencebased clinical practice guidelines. Chest. 129, 132S (2006).
  25. Pratter, M. R., Brightling, C. E., Boulet, L. P. and Irwin, R. S. : An empiric integrative approach to the management of cough: ACCP evidence-based clinical practice guidelines. Chest. 129, 222S (2006).
  26. Joseph T. Dipiro, Robert L. Talbert, Gary C. Yee, Gary R. Matzke, Barbara G. Wells, L. and Michael Posey : Pharmacotherapy A Pathophysiologic Approach 7th ed. Mc Graw Hill. pp. 463-518 (2008).
  27. British Thoracic Society of Cough Guideline Group : Recommendations for the management of cough in adults. Thorax. 61, i1 (2006).
  28. NICE. Management of chronic obstructive pulmonary disease in adults in primary and secondary care 2004. Available at http://guidance.nice.org.uk/CG012. Accessed on September 5 (2009).
  29. Braman, S. S. : Chronic cough due to chronic bronchitis: ACCP evidence-based clinical practice guidelines. Chest. 129, 104S (2006).
  30. Institute for Clinical Systems Improvement (ICSI), Diagnosis and Management of Chronic Obstructive Pulmonary Disease (COPD). Available at http://www.icsi.org/chronic_obstructive_pulmonary_disease/chronic_obstructive_pulmonary_disease_ 2286.html. Accessed on September 6 (2009).
  31. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, Available at http:// www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId= 2003. Accessed on September 6 (2009).
  32. Qaseem, A., Snow, V., Shekelle, P., Sherif, K., Wilt, T. J., Weinberger, S., Owens, D. K. : Clinical Efficacy Assessment Subcommittee of the American College of Physicians. : Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann. Intern. Med. 147, 633 (2007).
  33. 대한결핵 및 호흡기학회 만성폐쇄성폐질환 진료지침위원회 만성 기도폐쇄성질환 임상연구센터 : 만성폐쇄성폐질환의 진료지침 관련연구. Available at http://www.lungkorea.org/thesis/file/ COPD%c1%f8%b7%e1%c1%f6%c4%a7(05.11.7).pdf. Accessed on September 7 (2009).
  34. Global Initative for Asthma (GINA) : Global strategy for Asthma Management and Prevention, Available at http:// www.ginasthma.com/Guidelineitem.asp??l1=2&l2=1&intId= 1561. Accessed on September 8 (2009).
  35. National Asthma Education and Prevention Program (NAEPP) - National Heart Lung and Blood Institute, Expert Panel Report 3 (EPR3) : Guidelines for the Diagnosis and Management of Asthma, Available at http://www.nhlbi.nih.gov/guidelines/ asthma/asthgdln.htm. Accessed on September 8 (2009).
  36. BTS (The British Thoracic Society) & SIGN (Scottish Intercollegiate Guidelnes Network) : British Guideline on the Management of Asthma. Available at http://www.sign.ac.uk/ pdf/sign101.pdf. Accessed on September 8 (2009).
  37. Institute for Clinical Systems Improvement (ICSI) : Diagnosis and management of asthma. Available at http://www.icsi.org/asthma_outpatient/asthma_diagnosis_management_of_ guideline_.html. Accessed on September 9 (2009).
  38. Joint Task Force on Practice Parameters : Attaining optimal asthma control: a practice parameter. J. Allergy Clin. Immunol. 116, S3 (2005).
  39. 대학 결핵 및 호흡기학회 천식 진료지침 위원회, 기관지 천식의 진료 지침. Available at http://www.lungkorea.org/thesis/file/ %c3%b5%bd%c4%c1%f8%b7%e1%c1%f6%c4%a7(05.11.7).pdf. Accessed on September 9 (2009).
  40. 대한의학회 및 보건복지가족부, 한국 성인 천식의 진료지침 2007. Available at http://ncrc.cdc.go.kr/guideline/files/guideline/ 1256623696791.pdf. Accessed on September 9 (2009).